Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.1 USD | -5.98% | -7.56% | -18.52% |
Mar. 26 | Transcript : Biora Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | Biora Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Biora Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Biora Therapeutics, Inc.
HC Wainwright | |
BTIG | |
Piper Sandler | |
Baird | |
Raymond James | |
Wells Fargo Securities |
EPS Revisions
- Stock
- Equities
- Stock Biora Therapeutics, Inc. - Nasdaq
- Consensus Biora Therapeutics, Inc.